Delve into dermatology diseases with new approaches from conventional to complementary care.
Explore a broad spectrum of dermatological conditions and topics to enhance your practice.
Expert led instruction for every level of patient care.
Log in to see enrolled program content.
Gain practical insights and meet new colleagues.
Hover over a conference to view recordings.
The largest integrative dermatology community.
Afflicting hundreds of thousands of Americans every year, hidradenitis suppurativa (HS) is a common skin condition in which pimple-like boils appear on a patient’s skin. Even more common, psoriasis is the skin condition in which scaly dry patches form on a patient’s skin. Both skin diseases can be detrimental to the mental health of individuals suffering from these conditions. Patients with HS or psoriasis have a greater chance of heart attacks, must pay extensive health care costs, and face lower self-esteem as a result of their skin conditions.1–3 Examining these obstacles that HS and psoriasis patients face, researchers aimed to compare these patients’ quality of life to one another in their latest study.
Researchers compared HS and psoriasis patients from 5 previously published clinical trials.4 The quality of life of these patients was measured by the Visual Analog Scale (VAS) for pain, Total Work Productivity Impairment, Dermatology Life Quality Index, EuroQOL 5D VAS, and Short Form-36 Health Survey (mental and physical component scores).
On average, the HS patients experienced a lower quality of life than the psoriasis patients.
Specifically, HS patients experienced more bodily pain, worsened mental health outcomes, and lower work productivity than psoriasis patients. When the researchers examined the patients’ self-reported surveys, HS patients also reported that their skin condition impaired their daily lives more frequently. HS patients did score higher on the EuroQOL 5D VAS indicating more optimal health, but overall, HS patients reported worse quality of life than the psoriasis patients.
Hidradenitis Suppurativa | Psoriasis | |
---|---|---|
Visual Analog Scale (VAS) for Pain, 0 (no pain) to 100 (maximum pain) |
54.3* |
36.1* |
Short Form-36 Health Survey, 0 (poor health related quality of life (HRQoL)) to 100 (best HRQoL) |
Physical: 39.6* Mental: 41.5* |
Physical: 49.0* Mental: 47.5* |
EuroQOL 5D VAS, 0 (worst imaginable health) to 100 (best health) |
58.8* |
50.8* |
Total Work Productivity Impairment, 0 (no impairment) to 100 (maximum impairment) |
35.4* |
18.2* |
Dermatology Life Quality Index, 0 (no impairment on HRQoL) to 30 (maximum impairment of HRQoL) |
15.3* |
11.3* |
*Comparison of all values statistically significant between groups (p<0.05)
Both psoriasis and HS are debilitating skin conditions, but researchers never compared the consequences these skin conditions wrought on their patients with one another. Based on the study, HS patients may experience a worsened quality of life than their psoriasis counterparts, suggesting that the skin condition’s effects extend to the mental health of HS patients. This study emphasizes the need for more resources to better understand the complex skin disease that is hidradenitis suppurativa. Notably, this study does not mean to undermine the burden of patients who suffer from psoriasis, but rather to point to an area of dermatology that warrants further study.